VIVO
Meridian Bioscience Inc
VIVO
VIVO
Delisted
VIVO was delisted on the 30th of January, 2023.
170 hedge funds and large institutions have $363M invested in Meridian Bioscience Inc in 2019 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 63 increasing their positions, 50 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
18% less call options, than puts
Call options by funds: $139K | Put options by funds: $170K
Holders
170
Holding in Top 10
–
Calls
$139K
Puts
$170K
Top Buyers
| 1 | +$5.01M | |
| 2 | +$3.53M | |
| 3 | +$2.62M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$2.3M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$2.09M |
Top Sellers
| 1 | -$23.7M | |
| 2 | -$8.13M | |
| 3 | -$4.27M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$4.21M |
| 5 |
Goldman Sachs
New York
|
-$3.43M |